Skip to main content
. 2011 Nov 15;12(4):158–174. doi: 10.1120/jacmp.v12i4.3587

Table 1.

The dosimetric comparisons for DA‐VMAT and 7F‐IMRT.

Parameter Objective 7F‐IMRT DA‐VMAT p‐value
PTV50.4V95%
100%
99.13±0.18(98.8099.53)
99.01±0.32(98.599.75)
n/s
PTV50.4V100%
95%
95.09±0.34(94.6995.59)
95.13±0.23(94.7395.57)
n/s
PTV59.4V100%
95%
95.37±0.80(94.5696.78)
95.12±0.21(94.8795.49)
n/s
PTV72V100%
95%
95.54±0.39(94.7695.97)
95.41±0.27(94.8795.73)
n/s
PTV72V110%
5%
2.15±1.07(0.825.14)
1.70±0.83(03.21)
n/s
CI 1
1.27±0.05(1.211.37)
1.24±0.05(1.161.31)
n/s
HI 1
1.11±0.02(1.071.14)
1.09±0.02(1.071.13)
<0.05

Abbreviations: IMRT: intensity‐modulated radiotherapy; 7F: 7‐field fixed‐beam IMRT; DA‐VMAT: dual arcs with the SmartArc technique; PTV: planning target volume; V100%: volume receiving 100% of the prescribed dose for the 95% of PTV; V110%: no more than 5% of any PTV72 will receive 110% of the prescribed dose; CI: conformity index; HI: homogeneity index; statistical significance (p<0.05) is reported from a paired two‐side Wilcoxon signed‐rank test; n/s: not statistically significant; numbers in fields were shown in the format of mean±standarddeviation (range).